Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chung-Ang University Gwangmyeong Hospital | OTHER |
| Samsung Medical Center | OTHER |
| Korea University Ansan Hospital | OTHER |
| Kosin University Gospel Hospital |
Not provided
Not provided
Not provided
Not provided
This study was design to investigate the efficacy and safety of NOAC therapy in Koreans
East Asians have demonstrated a higher bleeding tendency compared to Western populations during an anticoagulation. Consequently, East Asians have been prescribed as a relatively weaker treatment regimens based on this evidence. Therefore, the TARGET-AF study aims to verify the efficacy and safety of NOAC therapy using biomarkers including TEG®-6S point-of-care device in Koreans
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Atrial Fibrillation | Documented AF on 12-lead ECG, Holter monitoring, or single-lead ECG recordings and biomarkers using TEG®-6S with NOAC treatment |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Clinical ischemic and hemorrhagic events | The Rate of Ischemic stroke, systemic embolism, or myocardial infarction and ISTH (International Society on Thrombosis and Hemostasis) major/minor bleeding events | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical other events | The rate of Major Adverse Cardiovascular Events: Myocardial infarction, ischemic stroke, systemic embolism, and cardiovascular death (including bleeding). | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| COVID-19 infection | The rate of confirmation of COVID-19 infection and primary outcome | 12 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
AF patients with NOAC
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong | South Korea | ||||
| Chung-Ang University Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36857519 | Background | Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae JS, Cho SY, Koh JS, Park Y, Hwang SJ, Gorog DA, Tantry US, Bliden KP, Gurbel PA, Hwang JY, Jeong YH. Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. Eur Heart J. 2023 May 14;44(19):1718-1728. doi: 10.1093/eurheartj/ehad088. |
Not provided
Not provided
CAUH 1992-002-387
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D020521 | Stroke |
| D006470 | Hemorrhage |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| OTHER |
| Keimyung University Dongsan Medical Center | OTHER |
| Yuhan Corporation | INDUSTRY |
Not provided
Not provided
Not provided
| Seoul |
| 06973 |
| South Korea |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |